Pediatric medical innovation is often overlooked by capital markets and funders for larger, less potentially risky adult biomedical market opportunities. Our startup initiatives promote a stronger foundation for pediatric innovation with greater impact by addressing two key unmet needs in the early-stage innovation pipeline: ready availability of complementary domain expertise and a supply of risk capital for exploration.
With your support, we aim to enable our committed and innovative clinicians to explore their high risk, high reward ideas to proof of concept and beyond.